Larvol Delta - BioPath-Holdings-Reports-Full-Year-2018-Financial-Results

Venclexta (venetoclax) - Roche, AbbVie

decitabine - generics

liposomal Bcl2 (BP-100-1.02) - Bio-path

prexigebersen (BP1001) - Bio-path

http://www.globenewswire.com/news-release/2019/03/20/1757845/0/en/Bio-Path-Holdings-Reports-Full-Year-2018-Financial-Results.html

Mar 20, 2019

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next